Table 1.

mRNA correlation and gene alteration of CaM and TAZ across all types of cancer.

Gene (Protein)	mRNA correlation coefficient †Spearman (p value)	Cases with genetic alteration (%)	Decreased survival of patients with altered genes Logrank Test p value
CALM1 (Calmodulin) WWTR1 (TAZ)	0.04 (p = 2.354e-5)	97/10950 (0.9%) 383/10950 (3%)	0.0302*
CALM2 (Calmodulin) WWTR1 (TAZ)	−0.11 (p = 4.27e-26)	108/10950 (1%) 383/10950 (3%)	0.0334*
CALM3 (Calmodulin) WWTR1 (TAZ)	−0.06 (p = 1.96e-9)	87/10950 (0.8%) 383/10950 (3%)	2.240e-3*

^*P <0.05

^†Spearman: 0–0.19 is regarded as very weak, 0.2–0.39 as weak, 0.40–0.59 as moderate, 0.6–0.79 as strong and 0.8–1 as very strong correlation.